Get started

Pharmastocks

Suven Pharma Breaks Out Like a Fever Dream"Suven Pharma Breaks Out Like a Fever Dream! 💊📈 #PharmaStocksGoBoom" I. Current Price Action: Price: ₹787.35 Change: +58.10 (+7.97%) Volume: 3.673M (Higher than the number of pills in your grandma's medicine cabinet!) II. Key Observations: Breakout Bonanza: SUVENPHAR has busted through its long-term resistance faster than a hypochondriac racing to WebMD. Side Channel Escape: The stock just broke out of its side channel, showing more excitement than a kid in a candy store (or should we say, pharmacy?). Volume Surge: Trading volume is higher than the line at the doctor's office during flu season. This suggests strong conviction in the move. Support Levels: The previous resistance around ₹760 could now act as support. If it holds, it'll be stronger than the taste of cough syrup. III. Trading Idea: For the brave pill-poppers (I mean, traders), riding this breakout could be more thrilling than reading the side effects on a medication leaflet. But remember, chasing stocks can be as dangerous as self-diagnosing on the internet! Potential Targets: 🎯 Short-term: ₹820 (As ambitious as promising to exercise more) 🎯 Mid-term: ₹850 (Reaching for the stars, or at least the top shelf of the medicine cabinet) IV. Risks: If this breakout fails, the stock could drop faster than your New Year's resolution to eat healthier. Keep an eye on overall market health and be ready to take your profits before they expire like old medication. V. Final Thoughts: Suven Pharmaceuticals has finally broken out of its consolidation, potentially setting the stage for a rally that could cure your portfolio's ailments. Will it continue to climb, or suffer from nasty side effects? Only time will tell, but one thing's for sure – this stock is more exciting than reading the fine print on a prescription label! Disclaimer: This analysis is about as reliable as WebMD's symptom checker. Always do your own research and consult a financial advisor before making investment decisions. Happy trading, and may your profits be as plentiful as the pills in a pharmacy! 💊🚀
NSE:SUVENPHARLong
by TRADING-NASA
MARKSANS PHARMA is in Wave 3 after Multi-Year Breakout!!Analysis Date: June 24, 2024 Marksans Pharma Stock Analysis: General Trend: The stock was in range for years, the previous monthly high for Marksans Pharma was Rs. 115 in August 2015. According to Elliott Wave theory, this marked the completion of Wave 1, followed by a correction and completion of Wave 2 on March 2020 and entered Wave 3. A breakout above the previous monthly high of Rs. 115.10 was recorded in July 2023. In August, September, and October 2023, the price retested the previous high and broke out again in November, accompanied by good volume. Entry and Exit Points: As per ichimoku the stock still in bull mode in monthly time frame and good accumulation last few months between 140-180. Long-term Perspective: The accumulation price range is a good area to buy the stock, with a stop loss set at Rs. 110 (monthly candle close not spike). Short-term Perspective: Fresh buyers can enter at CMP 162 and keep averaging till near the bottom of the accumulation zone and exit near the high of the range or hold or for two supply zones till 270. The stop loss will be1 hour candle close below RS. 135. Expected Target: Marksans Pharma is expected to hit supply zone 1 and 2 marked in the chart, once it breaks out of the accumulation zone. This target is derived based on the application of Fibonacci extension. Disclaimer: We are not SEBI registered. The content presented here is based on our personal opinions. Conduct your own research and consult with a qualified financial advisor before making any investment decisions.
NSE:MARKSANSLong
by WaveMoku
Daily Bullish Flag Breakout in Pharma stockA Bullish Breakout of Flag and Pole pattern is visible on the Weekly chart of NSE:POLYMED MACD already gave Positive crossover on Daily and Monthly chart. So, expecting the momentum to continue. One can create a fresh position in the scrip as per the levels mentioned on the chart. HIT THE ROCKET BUTTON IF YOU LIKE TO BOOST THE IDEA. Risk Disclaimer: The information provided in this analysis is based on my personal interpretation of market conditions and the available data at the time of writing. It is advisable to seek advice from a qualified financial professional and to conduct your own research before making any investment decisions.
NSE:POLYMEDLong
by raigvivek
Supriya Lifeciences Episodic Pivot TradeSupriya Lifesciences made a gap up (episodic pivot) on 8th Feb due to its blockbuster earnings, intresting part is even in the carnage of Smallcap & Midcaps the gap has been sustained continuously for 3 consecutive days, and never did it break the low of the EP candle. This shows strength in the scrip and I believe in the coming days once the market recovers, this scrip will move easily towards 400, 440 zone. Stoploss 312 DISCLAIMER* This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
NSE:SUPRIYALong
by nishant_bhatt
DIVIS LAB: H&S ContinuationFrom Mar'23 bottom of 2730 stock has rallied and made a high of 3934 in Aug'23. Post that stock has undergone into a correction which already concluded at Nov'23 bottom of 3295. From there stock has rallied again and broken it's previous swing high made in Aug'23. The recent price action suggests that stock has formed a Continuation H&S and given a breakout on 26th dec'23 and trading well above it's neckline. The measured target for this pattern is coming in the region of 4370-4400 zone.
NSE:DIVISLABLong
by TradingSutra
NGL Fine Chem Ltd | a Momentum pharma stockNGL Fine Chem Ltd | a Momentum pharma stock Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products. Financial: Market Cap = 1,382 Cr. ROCE = 11.5 % ROE = 9.31 % Debt to equity = 0.11 Promoter holding = 73.1 % Piotroski score = 4.00 Quick ratio = 2.06 Current ratio = 2.58 Return on assets = 7.11 % Profit Var 3Yrs = 18.5 % Sales growth 3Years = 21.8 % Pledged percentage = 0.00 % in Technically you can see monthly and weekly strong RSI Momentum financially also debt free company as well as company has good capex plan in comming years so this will be next multibagger if hold for long time. Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation. If you like my ideas than like ,boost and follow me for more ideas. Thanks and comment freely
NSE:NGLFINELong
by Momentuminvesting5540
Sequent Scientific PE is negative at -42 THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition mutual funds have increased stake from 0.25% to 1% DII also increasing stake significantly stock has come out of accumulation Phase!!!
NSE:SEQUENTLong
by rsptraders2017